Literature DB >> 12075576

Obesity is associated with decreasing levels of the circulating soluble leptin receptor in humans.

V Ogier1, O Ziegler, L Méjean, J P Nicolas, A Stricker-Krongrad.   

Abstract

OBJECTIVE: Leptin plays a major role in the regulation of body weight. It circulates in both free and bound form. One of the leptin receptor isoforms exists in a circulating soluble form that can bind leptin. In the present study, we measured the soluble leptin receptor (SLR) levels in lean and obese humans. We investigated the relationship between plasma SLR levels, plasma leptin levels and the degree of obesity. We also examined whether SLR concentrations could be modulated by fat mass loss induced by a 3 month weight-reducing diet.
SUBJECTS: A total of 112 obese (age 18-50 y; body mass index (BMI) 30-44 kg/m2; 23 men and 89 women), 38 overweight (age 19-48 y; BMI 25-29 kg/m2; 10 men and 28 women) and 63 lean (age 18-50 y; BMI 17-24 kg/m2; 16 men and 47 women) humans. MEASUREMENTS: A direct double monoclonal sandwich enzyme-linked immunosorbent assay (ELISA) was used for the quantitative measurement of the soluble human leptin receptor. Leptin was measured by radioimmunoassay (RIA). Body composition was assessed by biphotonic absorptiometry DEXA (dual energy X-ray absorptiometry).
RESULTS: We observed that the SLR is present in human plasma (range 10-100 ng/ml). SLR levels were lower in obese and overweight than lean subjects (28.7+/-8.8, 40.2+/-14.9, 51.2+/-12.5 ng/ml, respectively) and were inversely correlated to leptin and percentage of body fat (r=-0.74 and r=-0.76; respectively; P<0.0001). The ratio of circulating leptin to SLR was strongly related to the percentage of body fat (r=0.91; P<0.0001). Interestingly a gender difference was observed in SLR levels, which were higher in obese and overweight men than in obese and overweight women. In obese subjects after a 3 month low-calorie diet, SLR levels increased in proportion to the decrease in fat mass. In the gel filtration profile, SLR coeluted exactly with the bound leptin fractions.
CONCLUSION: Obesity, in humans is associated with decreasing levels of the circulating soluble leptin receptor (SLR). The relationship of SLR with the degree of adiposity suggests that high SLR levels may enhance leptin action in lean subjects more than in obese subjects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12075576     DOI: 10.1038/sj.ijo.0801951

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  20 in total

Review 1.  The impact of leptin on perinatal development and psychopathology.

Authors:  Jeanette C Valleau; Elinor L Sullivan
Journal:  J Chem Neuroanat       Date:  2014-05-23       Impact factor: 3.052

2.  Hyperphagia and leptin resistance in tissue inhibitor of metalloproteinase-2 deficient mice.

Authors:  H M Stradecki; D M Jaworski
Journal:  J Neuroendocrinol       Date:  2011-03       Impact factor: 3.627

3.  Mid-pregnancy maternal leptin levels, birthweight for gestational age and preterm delivery.

Authors:  Monal R Shroff; Claudia Holzman; Yan Tian; Rhobert W Evans; Alla Sikorskii
Journal:  Clin Endocrinol (Oxf)       Date:  2013-04       Impact factor: 3.478

4.  Low IGF-1 levels are associated with cardiovascular risk factors in haemodialysis patients.

Authors:  Abdishakur M Abdulle; Michael P T Gillett; Samra Abouchacra; Sufyan M Sabri; Mona Al Rukhaimi; Enyioma N Obineche; Jaipaul Singh
Journal:  Mol Cell Biochem       Date:  2007-03-27       Impact factor: 3.396

5.  Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway Underlies Altered Pain Perception in Leptin Signaling Deficiency.

Authors:  Luigia Cristino; Livio Luongo; Roberta Imperatore; Serena Boccella; Thorsten Becker; Giovanna Morello; Fabiana Piscitelli; Giuseppe Busetto; Sabatino Maione; Vincenzo Di Marzo
Journal:  Neuropsychopharmacology       Date:  2015-06-17       Impact factor: 7.853

6.  Regulation of circulating leptin and its soluble receptor during pubertal development in the male rhesus monkey (Macaca mulatta).

Authors:  David R Mann; Ganapathy K Bhat; Suresh Ramaswamy; Christine D Stah; Tony M Plant
Journal:  Endocrine       Date:  2007-04       Impact factor: 3.633

7.  Leptin replacement restores supraspinal cholinergic antinociception in leptin-deficient obese mice.

Authors:  Wenfei Wang; Helen A Baghdoyan; Ralph Lydic
Journal:  J Pain       Date:  2009-04-19       Impact factor: 5.820

8.  Cerebrospinal fluid levels of leptin, proopiomelanocortin, and agouti-related protein in human pregnancy: evidence for leptin resistance.

Authors:  Gabrielle Page-Wilson; Elena Reitman-Ivashkov; Kana Meece; Anne White; Michael Rosenbaum; Richard M Smiley; Sharon L Wardlaw
Journal:  J Clin Endocrinol Metab       Date:  2012-11-01       Impact factor: 5.958

9.  Preadipocyte transplantation: an in vivo study of direct leptin signaling on adipocyte morphogenesis and cell size.

Authors:  Kaiying Guo; Jonathan Mogen; Samuel Struzzi; Yiying Zhang
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-04       Impact factor: 3.619

10.  Leptin and soluble leptin receptor levels in plasma and risk of type 2 diabetes in U.S. women: a prospective study.

Authors:  Qi Sun; Rob M van Dam; James B Meigs; Oscar H Franco; Christos S Mantzoros; Frank B Hu
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.